3334 Insurance Generosity and Inflammatory Bowel Disease: Does Higher Patient Cost-Sharing Result in Suboptimal Medication Habits and Inferior Clinical Outcomes?

OBJECTIVES/SPECIFIC AIMS: Our primary objectives were to examine the impact of biologic cost sharing on 1) adherence to biologics and 2) persistence on biologics in inflammatory bowel disease (IBD) patients. Our secondary objective was to assess the effect of biologic cost sharing on clinical IBD ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Sceats, Lindsay Anne, Kin, Cindy, Trickey, Amber, Polyakova, Maria, Kate Bundorf, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Translational Science, Policy, & Health Outcomes Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798887/
http://dx.doi.org/10.1017/cts.2019.336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798887/
http://dx.doi.org/10.1017/cts.2019.336

Ejemplares similares